Want to create an interactive transcript for this episode?
Podcast: Empowering Midlife Wellness with Dr. Susan
Episode: Microdosing GLP-1: A New Approach to Inflammation-Driven Diseases
Description: When most people hear about GLP-1 medications like semaglutide or tirzepatide, they immediately think about diabetes or weight loss. In this video, I share a different perspective: the potential role of GLP-1 receptor agonists at microdoses in conditions where chronic inflammation is central to disease progression.
We know that inflammation underlies many disorders — from autoimmune disease to neurodegenerative conditions. While there are currently no large-scale clinical studies on microdosing GLP-1s for these indications, there are intriguing reasons to consider their potential. GLP-1 medications have been shown to influence metabolic pathways, reduce systemic inflammation, and even demonstrate neuroprotective properties in so...